2004
DOI: 10.1167/iovs.04-0059
|View full text |Cite
|
Sign up to set email alerts
|

Photoreceptor Protection by Iris Pigment Epithelial Transplantation Transduced with AAV-Mediated Brain-Derived Neurotrophic Factor Gene

Abstract: Transplantation of AAV2-BDNF-IPE cells may be an alternative method of delivering neurotrophic factors to the lesion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2005
2005
2012
2012

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 40 publications
1
9
0
Order By: Relevance
“…Our long-term goal is to develop a treatment for patients with AMD or RP. Together with the previous reports that BDNF-expressed IPE cells support the survival of the retinal cells, 15,58 our report shows that this technique of transplanting autologous IPE cells transfected with an appropriate growth factor gene via rAAV2 is a useful method of treating retinal degenerative diseases.…”
Section: Figuresupporting
confidence: 84%
“…Our long-term goal is to develop a treatment for patients with AMD or RP. Together with the previous reports that BDNF-expressed IPE cells support the survival of the retinal cells, 15,58 our report shows that this technique of transplanting autologous IPE cells transfected with an appropriate growth factor gene via rAAV2 is a useful method of treating retinal degenerative diseases.…”
Section: Figuresupporting
confidence: 84%
“…Further studies are needed to confirm effects of phagocytic activities in vivo. Our final goal is to protect photoreceptor cells by the subretinal transplantation of iris pigment epithelial (IPE) cells transduced by using a BDNF gene (Hojo et al, 2004). Changes in phagocytic activities reported here might provide keys to our final goal.…”
Section: Discussionmentioning
confidence: 98%
“…Cultured cells were incubated with 20% goat serum in PBS and then incubated with the different primary antibodies (Table 1) overnight at 4°C followed by a PBS wash. The cells were then incubated for 60 min with a fluorescence-conjugated secondary antibody followed by a PBS wash, and nuclei were then counterstained with Hoechst 33342 (SigmaAldrich) or propidium iodide (PI; Sigma-Aldrich) according to previous protocols (Hojo et al 2004). BrdU labeling was performed according to protocols used by Hojo et al (2004).…”
Section: Immunocytochemistrymentioning
confidence: 99%
“…The cells were then incubated for 60 min with a fluorescence-conjugated secondary antibody followed by a PBS wash, and nuclei were then counterstained with Hoechst 33342 (SigmaAldrich) or propidium iodide (PI; Sigma-Aldrich) according to previous protocols (Hojo et al 2004). BrdU labeling was performed according to protocols used by Hojo et al (2004). Fluorescence was visualized with either a Leica microscope (DMIRE2, Leica Microsystems) or a confocal microscope (Leica TCS NT; Leica Microsystems).…”
Section: Immunocytochemistrymentioning
confidence: 99%